Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVR and ONLY ADVR -- Ignore unavailable to you. Want to Upgrade?

To: DAN LITTLE who wrote (73)	9/26/2000 12:19:50 AM
From: RickV	Read Replies (1) \| Respond to of 278

dan, what ever the ownership is between the companies i am sure when the negotiations come down toward the end one way or another licensing, royalties, or something to that aspect would be the key so therefore both groups would make money and both would be profitable and the product would get out to the sick in the world... that is my opinion only... rick

To: DAN LITTLE who wrote (73)	9/26/2000 9:37:31 AM
From: Bernie Bildman	Respond to of 278

I agree regarding as to "WHAT THE COMPANY BELIEVES". The bigger question is what THE COURT BELIEVES! As to Chuck Miller (Commonwealth), it's my understanding he was brought on board to help gain approval in foreign markets, and in general move the case for sale of Reticulose forward. He also started Commonwealth in order to distribute the drug. ADVR already had Reticulose, and Miller was brought on considerably after Friedland and Bregman started up ADVR. Mr. Fisher of Kings know way more than I about this, so he might be the one to give explanations.